In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents
- PMID: 8141567
- PMCID: PMC284409
- DOI: 10.1128/AAC.38.1.134
In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents
Abstract
The in vitro antimicrobial susceptibilities of 42 isolates of rapidly growing mycobacteria (Mycobacterium fortuitum, M. chelonae, and Mycobacterium species [other than M. fortuitum and M. chelonae]) to nine quinolones, including newer agents, two new aminoglycosides, and an aminocyclitol (trospectomycin) were determined by a broth microdilution method. The new quinolones, PD 117596, PD 127391, and PD 117558, showed excellent in vitro activities against M. fortuitum (MICs for 90% of isolates [MIC90s], 0.06, 0.06, and 0.12 microgram/ml, respectively). The MIC90 of ciprofloxacin for M. fortuitum was 0.5 microgram/ml. Only 14 to 28% of isolates of M. chelonae were susceptible to various quinolones. Most isolates of all three species were susceptible to the new aminoglycosides SCH 21420 and SCH 22591. The MIC90s of trospectomycin were 8 micrograms/ml for M. chelonae, 32 micrograms/ml for Mycobacterium species, and > 64 micrograms/ml for M. fortuitum.
Similar articles
-
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.Antimicrob Agents Chemother. 1992 Jan;36(1):180-4. doi: 10.1128/AAC.36.1.180. Antimicrob Agents Chemother. 1992. PMID: 1317144 Free PMC article.
-
In-vitro activity of quinolones and macrolides against mycobacteria.J Antimicrob Chemother. 1994 Sep;34(3):343-51. doi: 10.1093/jac/34.3.343. J Antimicrob Chemother. 1994. PMID: 7829409
-
In vitro antimicrobial susceptibilities of Nocardia species.Antimicrob Agents Chemother. 1993 Apr;37(4):882-4. doi: 10.1128/AAC.37.4.882. Antimicrob Agents Chemother. 1993. PMID: 8494385 Free PMC article.
-
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.Clin Ther. 2004 Feb;26(2):191-6. doi: 10.1016/s0149-2918(04)90018-5. Clin Ther. 2004. PMID: 15038942 Review.
-
In-vitro activities of quinolones against mycobacteria.J Antimicrob Chemother. 1993 Dec;32(6):797-808. doi: 10.1093/jac/32.6.797. J Antimicrob Chemother. 1993. PMID: 8144420 Review.
Cited by
-
Activity of quinolones against mycobacteria.Drugs. 1995;49 Suppl 2:67-75. doi: 10.2165/00003495-199500492-00011. Drugs. 1995. PMID: 8549419 Review.
-
Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins.J Antibiot (Tokyo). 2024 Sep;77(9):577-588. doi: 10.1038/s41429-024-00750-2. Epub 2024 Jun 18. J Antibiot (Tokyo). 2024. PMID: 38890386 Free PMC article.
-
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.J Clin Microbiol. 1996 May;34(5):1323-6. doi: 10.1128/jcm.34.5.1323-1326.1996. J Clin Microbiol. 1996. PMID: 8727932 Free PMC article.
-
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials.Antimicrob Agents Chemother. 2000 Jan;44(1):181-2. doi: 10.1128/AAC.44.1.181-182.2000. Antimicrob Agents Chemother. 2000. PMID: 10602744 Free PMC article.
-
Lesser known mycobacteria.J Clin Pathol. 1995 Aug;48(8):701-5. doi: 10.1136/jcp.48.8.701. J Clin Pathol. 1995. PMID: 7560192 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous